Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results.

ABSTRACT:

SUBMITTER: Hughes TP 

PROVIDER: S-EPMC5668492 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature